Cargando…
From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577339/ https://www.ncbi.nlm.nih.gov/pubmed/37718552 http://dx.doi.org/10.3350/cmh.2023.0359 |
| _version_ | 1785121305211699200 |
|---|---|
| author | Yeh, Ming-Lun Yu, Ming-Lung |
| author_facet | Yeh, Ming-Lun Yu, Ming-Lung |
| author_sort | Yeh, Ming-Lun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10577339 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Association for the Study of the Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105773392023-10-17 From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials Yeh, Ming-Lun Yu, Ming-Lung Clin Mol Hepatol Editorial The Korean Association for the Study of the Liver 2023-10 2023-09-18 /pmc/articles/PMC10577339/ /pubmed/37718552 http://dx.doi.org/10.3350/cmh.2023.0359 Text en Copyright © 2023 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Yeh, Ming-Lun Yu, Ming-Lung From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_full | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_fullStr | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_full_unstemmed | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_short | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_sort | from nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: updates of nomenclature and impact on clinical trials |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577339/ https://www.ncbi.nlm.nih.gov/pubmed/37718552 http://dx.doi.org/10.3350/cmh.2023.0359 |
| work_keys_str_mv | AT yehminglun fromnonalcoholicsteatohepatitismetabolicdysfunctionassociatedfattyliverdiseasetosteatoticliverdiseaseupdatesofnomenclatureandimpactonclinicaltrials AT yuminglung fromnonalcoholicsteatohepatitismetabolicdysfunctionassociatedfattyliverdiseasetosteatoticliverdiseaseupdatesofnomenclatureandimpactonclinicaltrials |